|
Jul 1
|
10 European Dividend Stocks That Could Beat Their U.S. Counterparts
|
|
Jul 1
|
Sanofi’s riliprubart gains ODD status from Japan’s MHLW for CIDP
|
|
Jul 1
|
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
|
|
Jul 1
|
Adagene announces up to $25 million strategic investment from Sanofi
|
|
Jun 30
|
Sanofi (ENXTPA:SAN) Gains Orphan Drug Status In Japan For CIDP Treatment
|
|
Jun 30
|
Hedge Fund Strategy Built on Catastrophes Taps Hot New Trend
|
|
Jun 30
|
ESTEVE to acquire medicine to treat medullary thyroid cancer
|
|
Jun 30
|
Press release: Availability of the Q2 2025 Aide mémoire
|
|
Jun 30
|
Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy
|
|
Jun 27
|
Kymera’s partnerships with Sanofi and Gilead drive value
|
|
Jun 26
|
Kymera weakness a buying opportunity, says Stifel
|
|
Jun 26
|
Morning Movers: General Mills dips following fourth quarter report
|
|
Jun 26
|
KYMR Collaborates With GILD; Stock Down on Sanofi Deal Update
|
|
Jun 26
|
Sanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across Massachusetts
|
|
May 23
|
Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More
|
|
May 22
|
Vigil Neuroscience to be acquired by Sanofi for $8.00 per share
|
|
May 22
|
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence
|
|
May 22
|
Sanofi buys Vigil Neuroscience for $470m in Alzheimer’s push
|
|
May 22
|
European Equities Close Lower in Thursday Trading; Eurozone Business Activity Swings to Contraction
|
|
May 22
|
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi
|